FREMONT, Calif., Jan. 7, 2011 /PRNewswire/ -- WaferGen Biosystems,
Inc. (OTC Bulletin Board: WGBS), a leading developer of
state-of-the-art genomic analysis systems, today announced that it
will present an overview of the company at the 4th Annual
OneMedForum Business Development and Investment Conference for
emerging healthcare and life science companies held concurrently
with the JP Morgan Healthcare Conference in San Francisco, January
11-13, 2011.
The presentation will occur at the Sir Francis Drake Hotel in
San Francisco on Wednesday, January 12, 2011 at 2:30 p.m. Pacific time. It will be Webcast
live and may be accessed at www.wafergen.com; and it will be
archived for 90 days.
WaferGen Biosystems, Inc. is a leader in the development,
manufacture and sale of state-of-the-art systems for genomic
analysis for the life science and pharmaceutical industries.
The company currently offers the breakthrough SmartChip
Real-Time PCR system, the next-generation Real-Time PCR system for
discovery and validation of biomarkers, or gene expression
patterns, on a single platform. The company believes that the
SmartChip system is ideal for researchers seeking to confirm
discoveries made with the growing use of next-generation
sequencing. In addition, the high throughput capabilities of
the SmartChip system enable scientists to extend their research
across large panels of genes, and hundreds of samples, at a
reasonable cost.
In addition, the company offers an innovative fee-based service
for gene-expression profiling using the SmartChip system. For
additional information, please see http://www.wafergen.com.
|
WaferGen
|
|
|
510-651-4450
|
|
|
|
|
Don Huffman, CFO
|
|
|
don.huffman@wafergen.com
|
|
|
|
|
Joyce Strand
|
|
|
joyce.strand@wafergen.com
|
|
|
SOURCE WaferGen Biosystems, Inc.